E71.52 X-linked adrenoleukodystrophy

Name of the Condition

• X-linked adrenoleukodystrophy

Summary

X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder that affects the nervous system and adrenal glands. It results from the accumulation of very long-chain fatty acids (VLCFAs), leading to damage to the myelin sheath around nerve cells and adrenal insufficiency.

Causes

X-ALD is caused by mutations in the ABCD1 gene on the X chromosome. This mutation disrupts the breakdown of VLCFAs, causing them to accumulate in tissues and damage the adrenal glands and nervous system.

Risk Factors

• Being male, as the condition is X-linked.
• Family history of X-ALD due to its hereditary nature.

Symptoms

• Progressive neurological deterioration.
• Adrenal insufficiency (Addison's disease).
• Behavioral changes, weakness, and spasticity.
• In severe cases, loss of vision, hearing, and mobility.

Diagnosis

Diagnosis involves blood tests to measure VLCFA levels, genetic testing to identify ABCD1 gene mutations, and MRI scans to detect changes in brain structures.

Treatment Options

• Corticosteroid replacement therapy: For adrenal insufficiency.
• Lorenzo's oil: To help normalize VLCFA levels, although effectiveness varies.
• Hematopoietic stem cell transplantation (HSCT): Stops disease progression in cerebral ALD if performed early.

Prognosis and Follow-Up

Prognosis depends on the disease subtype and timing of intervention. Early diagnosis and treatment may slow progression, but neurological damage can be irreversible. Regular monitoring of adrenal function and neurological status is essential.

Complications

• Irreversible neurological damage.
• Severe adrenal insufficiency.
• Loss of motor and sensory functions.

Lifestyle & Prevention

• Genetic counseling for families with a history of X-ALD.
• Regular medical check-ups to monitor adrenal and neurological health.

When to Seek Professional Help

Seek medical attention for symptoms like unexplained weakness, behavioral changes, or signs of adrenal insufficiency (e.g., fatigue, low blood pressure).

Tips for Medical Coders

Document the specific subtype of X-ALD (e.g., cerebral, adrenomyeloneuropathy) when available, as this may impact coding and clinical management. Ensure genetic testing results and VLCFA levels are documented to support the diagnosis.